# Nuclide record bms (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/bms/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "bms" ;
  schema:name "Bristol Myers Squibb"@en ;
  schema:alternateName "Bristol-Myers Squibb"@en, "Juno Therapeutics"@en, "Mirati Therapeutics"@en, "Celgene"@en, "American Regent, Inc."@en, "American Regent"@en, "YM BioSciences"@en ;
  schema:description "Pioneer of checkpoint inhibitors (Opdivo, Yervoy), now betting on the first successful bispecific ADC and alpha radiopharmaceuticals."@en ;
  schema:url <https://nuclide.cc/companies/bms/>, <https://www.bms.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Bristol_Myers_Squibb> ;
  owl:sameAs <http://www.wikidata.org/entity/Q266423> ;
  schema:citation <https://www.bms.com> ;
  schema:addressCountry "US" ;
  nuclide:related <https://nuclide.cc/isotopes/ac-225/> ;
  nuclide:drugs <https://nuclide.cc/drugs/ryz101/> .
